The Supreme Court’s recent ruling in the case *Monsanto Co. v. Durnell* has sparked significant controversy, particularly among supporters of the “Make America Healthy Again” (MAHA) movement. The decision, issued in a 7-2 vote, declared that Monsanto, the manufacturer of the popular weedkiller Roundup, cannot be held liable in state courts for failing to provide a warning about the potential cancer risks linked to its product. The court’s reasoning hinged on the assertion that federal regulations, specifically those overseen by the Environmental Protection Agency (EPA), dictate what warnings must appear on pesticide labels. Since the EPA has not mandated a cancer warning for glyphosate—the active ingredient in Roundup—the court ruled that state laws requiring such warnings are preempted by federal law.
The ruling has left many within the MAHA movement feeling betrayed. Prominent activists, who had long pushed for stricter regulation of pesticides and greater transparency regarding their health risks, expressed disappointment and frustration. For them, the decision represents a betrayal of their core principles. Many had hoped that the Trump administration, which had aligned itself with MAHA in previous discussions, would support their push for stronger consumer protections. Instead, the administration appears to have prioritized the interests of pesticide manufacturers over public health concerns.
The case originated with John Durnell, a Missouri resident who developed non-Hodgkin’s lymphoma after using Roundup extensively over a period of more than 20 years. His lawsuit against Monsanto and its parent company, Bayer, was successful at the trial level, resulting in a $1.25 million award. However, the Supreme Court overturned that verdict, arguing that the EPA’s determination that glyphosate is not likely to be carcinogenic takes precedence over state-level findings. This has raised questions about the reliability of the EPA’s assessments, given that the World Health Organization’s International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans” in 2015.
Critics of the ruling argue that the court’s decision undermines the ability of individuals to seek redress for injuries caused by potentially dangerous products. They contend that the distinction between scientific inquiry and legal causation is being blurred. While scientific research often deals with probabilities and population-level trends, the legal system typically focuses on establishing a direct link between a product and an individual’s harm. This divergence has led to confusion and frustration among both plaintiffs and public health advocates.
The ruling has also highlighted tensions within the broader political landscape. While the Trump administration supported Monsanto’s position, many within the MAHA movement felt that their voices were not adequately represented. Health and Human Services Secretary Robert F. Kennedy Jr., who had previously championed stricter regulations on glyphosate, found himself in a difficult position as he aligned with the administration’s stance. His shift in rhetoric has drawn criticism from some MAHA supporters, who accuse him of abandoning his earlier commitments to public health advocacy.
The implications of the ruling extend beyond the immediate legal battle. With thousands of pending lawsuits against Bayer and Monsanto, the decision is expected to significantly reduce the number of cases that can proceed in state courts. Bayer, which had already set aside $16 billion to address these claims, has proposed a $7.25 billion class-action settlement. However, the outcome of this settlement remains uncertain, as it faces scrutiny from both plaintiffs and legal experts.
Environmental and public health advocates have condemned the ruling, viewing it as a step backward for consumer protection. They argue that the decision allows corporations to avoid accountability for potential health risks, even when scientific evidence suggests otherwise. Meanwhile, the agricultural sector has welcomed the ruling, seeing it as a validation of the importance of regulatory consistency and the role of federal agencies in determining product safety.
As the dust settles on this landmark decision, the path forward remains unclear. Legal challenges to the ruling are likely, and the impact on public policy and consumer rights will be closely watched. For now, the Supreme Court’s decision stands as a pivotal moment in the ongoing debate over the balance between corporate interests, regulatory oversight, and individual health concerns.
14 reports
The HillIndependentLeft5 days agoProminent members of the 'Make America Healthy Again' (MAHA) movement expressed anger and betrayal after the U.S. Supreme Court ruled in favor of Monsanto, stating that the company does not need to include a cancer risk warning on its Roundup weedkiller. This decision has raised concerns within the movement about the Republican Party's commitment to public health, especially since the Trump administration supported Monsanto in the case. Several studies, including a major one from last year, have linked glyphosate—the active ingredient in Roundup—to cancer, but Bayer and Monsanto have consistently denied this connection. Some MAHA supporters believe the ruling indicates that the administration prioritizes corporate interests over public health. The outcome may influence future voting patterns among MAHA members, with some considering shifting support to Democrats.
Bias read (Left): The article frames the Supreme Court's decision as a betrayal to public health advocates and highlights the frustration of MAHA members toward the Republican Party and the Trump administration. It emphasizes the perceived conflict between corporate interests and public health, using language that is
STAT NewsIndependentCenter6 days agoThe article discusses the Supreme Court's ruling in Monsanto v. Durnell, which ruled that federal pesticide law preempts state failure-to-warn claims regarding Roundup, even if the Environmental Protection Agency has not mandated a cancer warning. The decision highlights a growing disconnect between scientific findings and legal standards, particularly around the concept of 'causation.' While the International Agency for Research on Cancer (IARC) classified glyphosate as 'probably carcinogenic to humans' in 2015, regulatory agencies like the EPA and EFSA have not reached the same conclusion. The article argues that juries in litigation assess individual cases based on specific evidence rather than broad scientific consensus, leading to confusion in high-profile cases such as those involving Roundup and talc. Similar issues arise in talc litigation, where plaintiffs allege links to cancers like ovarian cancer or mesothelioma, though the IARC classification of talc as 'probably carcinogenic' does not equate to definitive proof of causation in every case.
Bias read (Center): The article presents a balanced discussion of the legal and scientific perspectives surrounding glyphosate and talc litigation. It does not overtly favor either side but emphasizes the structural differences between legal standards and scientific inquiry. The framing remains objective, focusing on a
Democracy Now!IndependentLeft7 days agoThe U.S. Supreme Court blocked thousands of cancer patients from suing Bayer/Monsanto over the herbicide Roundup, ruling that only the Environmental Protection Agency (EPA) can determine whether a chemical requires a warning label. The case involved a Missouri man who claimed exposure to Roundup caused his blood cancer, and a jury previously awarded him $1.25 million in damages. The Trump administration supported Bayer's position, asserting that Roundup is safe. Reporter Nate Halverson highlighted concerns that the EPA relied on studies ghostwritten by Monsanto, despite knowing the company's involvement. These lawsuits led to over $12 billion in settlements and revealed internal Monsanto communications showing awareness of potential health risks linked to glyphosate.
Bias read (Left): The article emphasizes the role of regulatory agencies like the EPA and highlights concerns about corporate influence on scientific research, suggesting skepticism toward the safety claims made by Bayer/Monsanto. It frames the Supreme Court decision as limiting state-level accountability and focuses
STAT NewsIndependentRight7 days ago Supreme Court rules in weedkiller cancer caseThe Supreme Court ruled that manufacturers of the weedkiller Roundup cannot face failure-to-warn lawsuits in state courts, as federal regulators have determined there is unlikely to be a cancer risk linked to the product. This decision is expected to prevent thousands of lawsuits against Bayer, which previously set aside $16 billion to settle similar cases and had proposed a $7.25 billion class-action settlement. Bayer has since removed glyphosate, the active ingredient in Roundup, from its U.S. products. The ruling aligns with the Trump administration's stance but highlights tensions within conservative groups over environmental and health policies.
Bias read (Right): The article frames the Supreme Court's decision as a 'blow to the Make America Healthy Again movement' and notes alignment with the Trump administration's views, implying support for deregulation and industry interests. The phrasing suggests a pro-industry perspective without adequately presenting a
STAT NewsIndependentRight8 days ago Supreme Court ruling blocks thousands of lawsuits against maker of Roundup weedkillerThe U.S. Supreme Court ruled 7-2 in favor of Bayer, the maker of Roundup weedkiller, blocking thousands of lawsuits claiming the product caused cancer due to inadequate warnings. The decision, which aligns with federal regulations that classify glyphosate as not likely to cause cancer when used properly, allows Bayer to avoid state-level failure-to-warn lawsuits. The ruling is seen as a win for President Trump’s administration but faces criticism from environmental groups and attorneys who argue it denies victims access to justice. While Bayer plans to move forward with a $7.25 billion class-action settlement, critics say the decision undermines public health protections and ignores conflicting scientific assessments of glyphosate’s safety.
Bias read (Right): The article frames the Supreme Court's decision as a positive outcome for 'science, farmers, and industries,' aligning with conservative values that prioritize regulatory clarity and corporate interests over individual health concerns. The emphasis on federal regulation over state law reflects a pro
CBS News (US)IndependentCenter8 days agoThe U.S. Supreme Court ruled 7-2 in favor of Monsanto in a case involving the cancer risks associated with its weedkiller Roundup. The court determined that state laws cannot hold Monsanto liable for not including cancer warnings on Roundup's labels, citing a federal law that mandates the use of EPA-approved labels. The Environmental Protection Agency has classified Roundup as safe and does not require a cancer warning on its label. This decision is expected to prevent thousands of lawsuits against Monsanto, many of which were filed by individuals claiming that exposure to Roundup caused cancer. Bayer, which acquired Monsanto in 2018, stated that the ruling supports scientific integrity and regulatory clarity, and plans to proceed with a proposed $7.25 billion class-action settlement.
Bias read (Center): The article presents the Supreme Court's decision neutrally, focusing on the legal reasoning and implications rather than taking a stance on the issue of Roundup's safety or the validity of the cancer claims. It includes perspectives from both the court and Bayer but avoids overtly biased language.
The New York Times (US)Independent🔒Center8 days agoThe U.S. Supreme Court has rejected a lawsuit against Bayer, the manufacturer of the weedkiller Roundup, which was alleged to have caused cancer. This decision could influence the outcome of thousands of similar lawsuits pending against the company. The ruling suggests that the court will not intervene in these cases, leaving them to proceed in lower courts. The issue has been a significant legal challenge for Bayer, with numerous plaintiffs claiming health damage due to exposure to Roundup. The rejection of this particular case may set a precedent for how such lawsuits are handled moving forward.
Bias read (Center): The article presents a factual report on the Supreme Court's decision without apparent ideological framing. It does not use emotionally charged language nor favor one side over another. The focus is on the legal implications rather than taking a stance on the product's safety or the validity of the訴
NPR NewsIndependentCenter8 days agoThe U.S. Supreme Court ruled in favor of Monsanto in a case involving the herbicide Roundup. The case, brought by Missouri resident John Durnell, centered on the determination of what information should appear on pesticide labels and whether federal law supersedes state-level claims regarding product liability. The court's decision likely reinforces the regulatory framework under which pesticides are labeled and sold in the United States, potentially limiting the ability of individuals to pursue legal action based on state laws. This ruling has implications for both consumers and manufacturers, affecting how product safety and liability are managed across different jurisdictions.
Bias read (Center): The article presents the Supreme Court's decision without overtly endorsing either side of the argument. It focuses on the legal interpretation rather than taking a clear ideological stance. While the outcome favors a corporate entity, the framing remains neutral, emphasizing the legal process and a
ABC News (US)IndependentCenter8 days agoThe U.S. Supreme Court ruled that thousands of lawsuits against Bayer, the maker of Roundup weedkiller, cannot proceed in state courts due to federal regulations that deem the product's key ingredient, glyphosate, unlikely to cause cancer. This decision comes after a surge of litigation, including several multibillion-dollar verdicts against Bayer, which acquired Roundup through its purchase of Monsanto in 2018. The case was brought by Missouri resident John Durnell, who claimed he developed non-Hodgkin’s lymphoma after using Roundup for over two decades. While the World Health Organization classified glyphosate as 'probably carcinogenic' in 2015, the Environmental Protection Agency has concluded it is not likely to cause cancer when used as directed. Bayer argues it must comply with federal labeling standards rather than state laws, and has set aside significant funds to address ongoing legal challenges.
Bias read (Center): The article presents both sides of the issue, citing the World Health Organization's classification of glyphosate as 'probably carcinogenic' and the EPA's determination that it is not likely to cause cancer when used as directed. It also mentions the political implications of the ruling, noting that
Associated PressIndependentCenter8 days agoThe U.S. Supreme Court has ruled to block thousands of lawsuits against Monsanto, the manufacturer of the popular weedkiller Roundup. The decision effectively halts ongoing litigation related to claims that Roundup causes cancer. This ruling comes after years of legal battles where plaintiffs argued that exposure to the herbicide led to non-Hodgkin lymphoma and other health issues. The court's decision was based on procedural grounds, stating that the cases should have been consolidated under federal law rather than handled individually in state courts. This outcome provides significant legal protection for Monsanto and potentially limits future liability for the company.
Bias read (Center): The article presents the Supreme Court's decision neutrally, focusing on the legal reasoning and implications without overtly favoring either side. It does not include biased language or selective sourcing that would indicate a clear ideological lean.
The HillIndependentRight8 days ago Supreme Court protects pesticides from some health claims in key Roundup caseThe U.S. Supreme Court ruled 7-2 that certain health risk claims against pesticide manufacturers like Monsanto cannot be pursued in lawsuits, citing federal law restrictions. The decision limits consumers' ability to sue over alleged health harms linked to products such as Roundup. The ruling blocks claims that assert pesticide companies failed to adequately warn users about potential health risks. This decision has significant implications for product liability and consumer rights, potentially shielding companies from specific types of litigation.
Bias read (Right): The article frames the Supreme Court's decision as a limitation on consumer lawsuits, which aligns with conservative judicial philosophy emphasizing limited government intervention and protecting corporate interests. The focus on restricting legal claims against pesticide companies suggests a pro-cy
National ReviewIndependentCenter10 days agoThe U.S. Supreme Court is considering cases that examine the origins of the power to file lawsuits. The court is carefully reviewing three cases to determine the legal basis for the right to sue, focusing on where this authority comes from within the legal system.
Bias read (Center): The article presents a neutral description of the Supreme Court's consideration of cases related to the right to sue, without apparent bias toward either side of the issue. It does not use loaded language, present one-sided sourcing, or omit relevant context.
Bloomberg NewsIndependent🔒Right10 days agoThe U.S. Supreme Court has decided that non-U.S. citizens can no longer file lawsuits in U.S. courts regarding international human rights violations. This ruling marks a significant shift in the country's approach to human rights enforcement. Bloomberg Opinion columnist and Harvard Law Professor Noah Feldman argues that this decision signifies the end of the U.S. era of protecting human rights. The ruling affects how international human rights issues are addressed through U.S. legal channels, potentially limiting avenues for justice for non-citizens affected by such violations.
Bias read (Right): The article presents the Supreme Court's decision as an 'abandonment of the cause' and frames it as the 'end of the U.S. era of protecting human rights,' which implies a negative judgment on the ruling and aligns with a critique of the current administration's stance on human rights. The framing ofU
Mother JonesIndependentLeft10 days agoMother Jones reports that the Environmental Protection Agency (EPA) continued to rely on a significant glyphosate study despite being informed that Monsanto had acted as a 'ghost writer' in its creation. Glyphosate is the active ingredient in Roundup, a widely used herbicide produced by Monsanto, now owned by Bayer. The study in question was conducted by the Council for Agricultural Science and Technology (CAST), which has been criticized for having close ties to agribusiness interests. The article highlights concerns over potential conflicts of interest and the influence of corporate funding on scientific research. This reliance raises questions about the integrity of regulatory decisions based on such studies.
Bias read (Left): The article frames the situation as a conflict of interest involving corporate influence on regulatory science, suggesting that the EPA's actions were compromised by reliance on potentially biased research. The tone implies skepticism toward the EPA's decision-making process and highlights the power
★
Keep the news honest.
ObjectiveNews is reader-funded and ad-free — we show you the bias instead of hiding it. Support independent journalism for €5/month.
Become a Supporter
United States
